The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five ...

Breast cancer remains a top health concern globally, especially in India where detection rates are low. AI is revolutionizing ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

Cancer detection rates were 6·4 per 1,000 screened in the group that underwent mammography with AI use compared to five per 1 ...

NHS clinics will use artificial intelligence to screen for breast cancer in a massive “landmark” trial. Almost 700,000 ...

New research results now published from Lund University's MASAI trial are even better than the initial findings from last ...

The broadcaster was diagnosed with breast cancer in 2021 and appeared on Good Morning Britain to discuss a new NHS trial ...

Artificial Intelligence enables earlier detection, faster treatment decisions and precision treatment, but data quality and ...

NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in ...

AI tools like the ones being tested in the EDITH trial could help facilitate the screening process, allowing the NHS to ...